Dimensional Fund Advisors’s Precision BioSciences DTIL Stock Holding History

Dimensional Fund Advisors’s Portfolio DTIL Stock Details DTIL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-23,757	Closed	-$98.8K	–	3239
2025 Q4	$98.8K	Sell	23,757 -19,884	-46%	-$113K	﹤0.01%	3149
2025 Q3	$241K	Sell	43,641 -9,990	-19%	-$47.8K	﹤0.01%	3097
2025 Q2	$225K	Hold	53,631	–	–	﹤0.01%	3099
2025 Q1	$256K	Sell	53,631 -1,844	-3%	-$9.39K	﹤0.01%	3098
2024 Q4	$211K	Buy	+55,475	New	+$405K	﹤0.01%	3159
2023 Q3	–	Sell	-3,182	Closed	-$50.2K	–	3480
2023 Q2	$50.2K	Sell	3,182 -8	-0.3%	-$183	﹤0.01%	3407
2023 Q1	$72.1K	Hold	3,190	–	–	﹤0.01%	3353
2022 Q4	$114	Hold	3,190	–	–	﹤0.01%	3307
2022 Q3	$125K	Sell	3,190 -2,686	-46%	-$128K	﹤0.01%	3306
2022 Q2	$282K	Sell	5,876 -3,413	-37%	-$200K	﹤0.01%	3189
2022 Q1	$858K	Sell	9,289 -465	-5%	-$63.2K	﹤0.01%	3029
2021 Q4	$2.17M	Buy	+9,754	New	+$2.72M	﹤0.01%	2835

Other funds holding DTIL

OCA

Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return

EAM

Empery Asset Management New York $83M AUM

Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return

BFM

Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

LCM

Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

AAA

Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Dimensional Fund Advisors's DTIL Position: Q1 2026 in Review

Dimensional Fund Advisors sold out of Precision BioSciences (DTIL) in Q1 2026, closing a stake of 23,757 shares — an estimated $98.8K sold.

Dimensional Fund Advisors first reported a position in DTIL in Q4 2021 and held it in 12 quarters. The position peaked at $2.17M in Q4 2021. 78 funds tracked by Wall St. Rank hold DTIL as of Q1 2026.

Dimensional Fund Advisors reported no remaining Precision BioSciences position as of Q1 2026 after selling out during the quarter.
Dimensional Fund Advisors sold 23,757 Precision BioSciences shares in Q1 2026, an estimated $98.8K.
Dimensional Fund Advisors first reported a position in Precision BioSciences in Q4 2021 and held it in 12 quarters.
Dimensional Fund Advisors's Precision BioSciences position peaked at $2.17M in Q4 2021.
78 funds tracked by Wall St. Rank held Precision BioSciences as of Q1 2026.

Based on Dimensional Fund Advisors's 13F filing for Q1 2026, filed 7 May 2026.